The present invention is directed towards compositions and methods for
reducing or controlling inflammation and for treating inflammatory
disease processes and other pathological conditions. The present
invention relates to mixtures comprising at least one oligosaccharide of
chitosan or a component thereof as novel pharmaceuticals, dietary
supplements or cosmetic compositions containing such mixtures, and to the
use of such mixtures for preparing a medicament or a dietary supplement
for the suppression of hypersensitivity reaction and/or inflammation in
human and animals.